Sanofi has announced that it is in exclusive negotiations for the sale of a 50% controlling stake in its consumer health division, Opella, to U.S.-based private equity firm Clayton Dubilier & Rice (CD&R). This move aligns with a broader trend among pharmaceutical companies to divest consumer health businesses, which are often less profitable compared to...
Premium Membership Required
You must be a Premium member to access this content.
Already a member? Log in here
